Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ: TELA )

2.240 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TELA Bio, Inc. - Common stock

< Previous 1 2 3 4 5 Next >
Earnings Scheduled For May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... 
Via Benzinga
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
Leader in innovative soft-tissue tissue reconstruction solutions sponsors event advocating for and mentoring women in surgery 
From TELA Bio, Inc.
Via GlobeNewswire
Why TELA Bio Stock Is Dropping Today
TELA Bio (NASDAQ: TELA) shares are trading lower after the company priced a 4.75 million share offering at $9.50 per share. 
Via Benzinga
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Participate in the JMP Securities Life Sciences Conference
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Announce First Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Preview: TELA Bio's Earnings
Via Benzinga
TELA Bio Announces Pricing of Public Offering of Common Stock
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Proposed Public Offering of Common Stock
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
Presentations highlight utility of this advanced hernia reinforcement material for robotic procedures 
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
Company continues design advancements of biologic-based materials for soft tissue repair and reinforcement 
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Earnings Scheduled For March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. 
Via Benzinga
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications
Recent research of OviTex® Reinforced Tissue Matrix demonstrated favorable results in various hernia and abdominal wall reconstruction applications 
From TELA Bio, Inc.
Via GlobeNewswire
Elon Musk A Frequent Flier In 2022 With Flights Lasting As Little As 13 Minutes, Says Report: His Love For Jet-Setting At Odds With Tesla's Climate Stance?
Tesla Inc. (NASDAQ: TELA) CEO Elon Musk is an entrepreneur who has his fingers in many pies, and undoubtedly time is money for him. 
Via Benzinga
TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
Company continues to expand innovative product portfolio to address surgeon needs 
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
Company grows product portfolio, expanding product offerings to optimize soft tissue preservation and restoration 
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
Coinbase To $80? Plus Deutsche Bank Cuts PT On This Stock By 80%
Citigroup cut the price target on Coinbase Global, Inc. (NASDAQ: COIN) from $105 to $80. Citigroup analyst Peter Christiansen maintained a Buy rating on the stock. Coinbase shares rose 2.1% to $46.95... 
Via Benzinga
TELA Bio Reports Third Quarter 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Earnings Outlook For TELA Bio
TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that TELA Bio will... 
Via Benzinga
TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Announce Third Quarter 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.